Nuveen Asset Management’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$54.1M Sell
1,798,989
-232,335
-11% -$6.99M 0.02% 619
2024
Q3
$47.5M Buy
2,031,324
+342,673
+20% +$8.02M 0.01% 689
2024
Q2
$30M Buy
1,688,651
+135,161
+9% +$2.4M 0.01% 875
2024
Q1
$23.6M Buy
1,553,490
+202,769
+15% +$3.08M 0.01% 1077
2023
Q4
$23.1M Buy
1,350,721
+968,611
+253% +$16.5M 0.01% 1058
2023
Q3
$3.19M Sell
382,110
-2,030
-0.5% -$17K ﹤0.01% 2091
2023
Q2
$9.54M Sell
384,140
-139,197
-27% -$3.46M ﹤0.01% 1535
2023
Q1
$7.87M Sell
523,337
-81,810
-14% -$1.23M ﹤0.01% 1632
2022
Q4
$7.16M Buy
605,147
+83,118
+16% +$983K ﹤0.01% 1704
2022
Q3
$3.09M Buy
522,029
+144,022
+38% +$852K ﹤0.01% 2162
2022
Q2
$1.61M Sell
378,007
-19,552
-5% -$83.1K ﹤0.01% 2549
2022
Q1
$3.86M Sell
397,559
-64,499
-14% -$626K ﹤0.01% 2192
2021
Q4
$7.22M Sell
462,058
-237,061
-34% -$3.71M ﹤0.01% 1882
2021
Q3
$21.9M Buy
699,119
+40,587
+6% +$1.27M 0.01% 1208
2021
Q2
$25.5M Sell
658,532
-18,077
-3% -$701K 0.01% 1180
2021
Q1
$32.6M Sell
676,609
-71,995
-10% -$3.47M 0.01% 981
2020
Q4
$38.9M Buy
748,604
+5,720
+0.8% +$298K 0.01% 835
2020
Q3
$19.9M Buy
742,884
+313,670
+73% +$8.39M 0.01% 1068
2020
Q2
$8.36M Sell
429,214
-203,499
-32% -$3.96M ﹤0.01% 1608
2020
Q1
$6.23M Buy
632,713
+319,255
+102% +$3.14M ﹤0.01% 1581
2019
Q4
$3.48M Buy
313,458
+15,450
+5% +$171K ﹤0.01% 2175
2019
Q3
$1.67M Buy
298,008
+1,822
+0.6% +$10.2K ﹤0.01% 2484
2019
Q2
$2.56M Buy
+296,186
New +$2.56M ﹤0.01% 2312